Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

67%

Ph phase_4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Detailed Status

Completed2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (33.3%)

N/A2 (66.7%)

Trials by Status

completed267%

recruiting133%

Recent Activity

1 active trials

Showing 3 of 3

recruitingnot_applicable

Shared Decision Making to Treat Or Prevent (STOP) HIV in Justice Populations (R33)

NCT07223398

completednot_applicable

STOP (Shared Decision Making to Treat Or Prevent) HIV in Justice Populations

NCT06439329

completedphase_4

Effects of Early Short-term Intravenous Iron Supplements Combined EPO in Preterm Infants

NCT02060851

Clinical Trials (3)

Showing 3 of 3 trials

NCT07223398Not Applicable

Shared Decision Making to Treat Or Prevent (STOP) HIV in Justice Populations (R33)

Recruiting

NCT06439329Not Applicable

STOP (Shared Decision Making to Treat Or Prevent) HIV in Justice Populations

Completed

NCT02060851Phase 4

Effects of Early Short-term Intravenous Iron Supplements Combined EPO in Preterm Infants

Completed

All 3 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 3